The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
PRO: The COVID-19 pandemic will result in increased antimicrobial resistance rates
Open accessAbstract
We argue that the COVID-19 pandemic will result in increased antimicrobial resistance (AMR). Broad-spectrum antibiotic use is common among hospitalized COVID-19 patients and in excess of reported secondary infection rates, suggesting unnecessary prescribing. Selection pressure is likely to be particularly intense in COVID-19 epicentres and within non-epicentre hospital units dedicated to COVID-19 care. Risk factors that increase the likelihood of hospitalization or poor outcomes among COVID-19 patients, such as advanced age, nursing home residence, debilitation, diabetes and cardiopulmonary or other underlying systemic diseases, also predispose to AMR infections. Worry for AMR emergence is heightened since first-wave COVID-19 epicentres were also AMR epicentres. Disruptive direct and indirect effects of COVID-19 globally on economic systems, governance and public health expenditure and infrastructure may fuel AMR spread. We anticipate that the impact of COVID-19 on AMR will vary between epicentres and non-epicentres, by geographic region, hospital to hospital within regions and within specific hospital units.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The phenomenon of cross-resistance between disinfectants and antimicrobials has been reported for several disinfectants and is associated with a further increase in AMR during the pandemic period [5, 10, 11].”
From Profiling the resistome and virulome of Bacillus strains used for probiotic-based sanitation: a multicenter WGS analysis (2025) · cites this paper as [11]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Consistent with this, during the COVID-19 pandemic, when chemical disinfection was significantly increased in both sanitary and non-sanitary settings, a significant increase in AMR was recorded [5, 10, 11, 21].”
From Profiling the resistome and virulome of Bacillus strains used for probiotic-based sanitation: a multicenter WGS analysis (2025) · cites this paper as [11]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rawson, T. M., Moore, L. S. P., Zhu, N., Ranganathan, N., Skolimowska, K., Gilchrist, M., Satta, G., Cooke, G., & Holmes, A. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa530 · Cited by 1,662
Antimicrobial Resistance: a One Health Perspective
McEwen, S. A., & Collignon, P. (2018) · Microbiology Spectrum · doi:10.1128/microbiolspec.arba-0009-2017 · Cited by 1,404
Epidemiology of Covid-19 in a Long-Term Care Facility in King County, Washington
McMichael, T. M., Currie, D. W., Clark, S., Pogosjans, S., Kay, M. K., Schwartz, N. G., Lewis, J., Baer, A., Kawakami, V., Lukoff, M. D., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2005412 · Cited by 1,358
Collignon, P., Beggs, J. J., Walsh, T. R., Gandra, S., & Laxminarayan, R. (2018) · The Lancet Planetary Health · doi:10.1016/s2542-5196(18)30186-4 · Cited by 750
Preparing for the Next Pandemic
Osterholm, M. T. (2005) · New England Journal of Medicine · doi:10.1056/nejmp058068 · Cited by 665
Multidrug-resistant bacterial infections in U.S. hospitalized patients, 2012-2017.
Jernigan, J. A., Hatfield, K. M., Wolford, H., Nelson, R. E., Olubajo, B., Reddy, S. C., McCarthy, N., Paul, P., McDonald, L. C., Kallen, A., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1914433 · Cited by 577
Carbapenem-Resistant Acinetobacter baumannii and Enterobacteriaceae in South and Southeast Asia
Hsu, L. Y., Apisarnthanarak, A., Khan, E., Suwantarat, N., Ghafur, A. K., & Tambyah, P. A. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00042-16 · Cited by 342
How covid-19 is accelerating the threat of antimicrobial resistance
Hsu, J. (2020) · BMJ · doi:10.1136/bmj.m1983 · Cited by 285
Coronavirus Disease 2019, Superinfections, and Antimicrobial Development: What Can We Expect?
Clancy, C. J., & Nguyen, M. H. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa524 · Cited by 275
Self-citationDissemination and Mechanism for the MCR-1 Colistin Resistance
Gao, R., Hu, Y., Li, Z., Sun, J. G., Wang, Q., Lin, J., Ye, H., Liu, F., Srinivas, S., Li, D., et al. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005957 · Cited by 271
Research works printed but not linked: 1
- Clancy, 2020, COVID–19, superinfections and antimicrobial development: what can we expect?, Clin Infect Dis
Cited by
Sorted by citations
Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis
Langford, B. J., So, M., Raybardhan, S., Leung, V., Soucy, J.-P. R., Westwood, D. J., Daneman, N., & MacFadden, D. R. (2021) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.12.018 · Cited by 934
Antimicrobial resistance and COVID-19: Intersections and implications
Knight, G. M., Glover, R. E., McQuaid, C. F., Olaru, I. D., Gallandat, K., Leclerc, Q. J., Fuller, N. M., Willcocks, S., Hasan, R., van Kleef, E., et al. (2021) · eLife · doi:10.7554/elife.64139 · Cited by 372
Antibiotic resistance associated with the COVID-19 pandemic: a systematic review and meta-analysis
Langford, B. J., Soucy, J.-P. R., Leung, V., So, M., Kwan, A. T. H., Portnoff, J. S., Bertagnolio, S., Raybardhan, S., MacFadden, D. R., & Daneman, N. (2022) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2022.12.006 · Cited by 249
O'Flynn, D., Lawler, J., Yusuf, A., Parle‐McDermott, A., Harold, D., Cloughlin, T. M., Holland, L., Regan, F., & White, B. (2021) · Analytical Methods · doi:10.1039/d0ay02098b · Cited by 101
Emerging Concern for Silver Nanoparticle Resistance in Acinetobacter baumannii and Other Bacteria
McNeilly, O., Mann, R., Hamidian, M., & Gunawan, C. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.652863 · Cited by 153
Karaba, S. M., Jones, G. F., Helsel, T., Smith, L., Avery, R. K., Dzintars, K., Salinas, A. B., Keller, S. C., Townsend, J., Klein, E. Y., et al. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa578 · Cited by 127
Dashtbani-Roozbehani, A., & Brown, M. H. (2021) · Antibiotics · doi:10.3390/antibiotics10121502 · Cited by 118
Microbial co-infections in COVID-19: Associated microbiota and underlying mechanisms of pathogenesis
Hoque, M. N., Akter, S., Mishu, I. D., Islam, M. R., Rahman, M. S., Akther, M., Islam, I., Hasan, M. M., Rahaman, M. M., Sultana, M., et al. (2021) · Microbial Pathogenesis · doi:10.1016/j.micpath.2021.104941 · Cited by 118
Antimicrobial consumption in patients with COVID-19: a systematic review and meta-analysis
Khan, S., Hasan, S. S., Bond, S. E., Conway, B. R., & Aldeyab, M. A. (2021) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2022.2011719 · Cited by 90
Clancy, C. J., Schwartz, I. S., Kula, B., & Nguyen, M. H. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab065 · Cited by 87
Self-citationJeon, K., Jeong, S., Lee, N., Park, M.-J., Song, W., Kim, H.-S., Kim, H. S., & Kim, J. (2022) · Antibiotics · doi:10.3390/antibiotics11040535 · Cited by 85
Wang, C.-Z., Mantilla-Calderon, D., Xiong, Y.-H., Alkahtani, M., Bashawri, Y. M., Qarni, H. A., & Hong, P. (2022) · Environmental Science and Technology · doi:10.1021/acs.est.2c01834 · Cited by 62
Ciğeroğlu, Z., Kazan-Kaya, E. S., Messaoudi, N. E., Fernine, Y., Américo‐Pinheiro, J. H. P., & Jada, A. (2022) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2022.120866 · Cited by 76
Sweileh, W. M. (2021) · Globalization and Health · doi:10.1186/s12992-021-00754-9 · Cited by 76
Antibiofilm peptides: overcoming biofilm-related treatment failure
Dostert, M., Trimble, M. J., & Hancock, R. E. W. (2021) · RSC Advances · doi:10.1039/d0ra09739j · Cited by 68
Buehrle, D. J., Decker, B. K., Wagener, M. M., Adalja, A. A., Singh, N., McEllistrem, M. C., Nguyen, M. H., & Clancy, C. J. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01011-20 · Cited by 60
Self-citationMulti-Drug Resistance Bacterial Infections in Critically Ill Patients Admitted with COVID-19
Pasero, D., Cossu, A. P., & Terragni, P. (2021) · Microorganisms · doi:10.3390/microorganisms9081773 · Cited by 60
Buehrle, D. J., Nguyen, M. H., Wagener, M. M., & Clancy, C. J. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa575 · Cited by 52
Self-citationKumar, M., Mazumder, P., Silori, R., Manna, S., Panday, D. P., Das, N., Sethy, S. K., Kuroda, K., Mahapatra, D. M., Mahlknecht, J., et al. (2023) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2023.166419 · Cited by 53
Lemenand, O., Coeffic, T., Thibaut, S., Colomb-Cotinat, M., Caillon, J., & Birgand, G. (2021) · Journal of Infection · doi:10.1016/j.jinf.2021.09.016 · Cited by 49
Zeshan, B., Karobari, M. I., Afzal, N., Siddique, A., Basha, S., Basheer, S. N., Peeran, S. W., Mustafa, M., Daud, N. H. A., Ahmed, N., et al. (2021) · Antibiotics · doi:10.3390/antibiotics11010035 · Cited by 48
Daneshnia, F., de Almeida, J. N., Arastehfar, A. A., Lombardi, L., Shor, E., Moreno, L., Mendes, A. V. A., Barberino, M. G., Thomaz, D. Y., Butler, G., et al. (2022) · Emerging Microbes & Infections · doi:10.1080/22221751.2022.2117093 · Cited by 47
Khoshbakht, R., Kabiri, M., Neshani, A., Khaksari, M. N., Sadrzadeh, S. M., Mousavi, S. M., Ghazvini, K., & Ghavidel, M. (2022) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-022-01159-y · Cited by 51
COVID-19: Impact on prescribing and antimicrobial resistance
Ruíz-Garbajosa, P., & Cantón, R. (2021) · Revista Española de Quimioterapia · doi:10.37201/req/s01.19.2021 · Cited by 45
The impact of the COVID-19 pandemic on antimicrobial resistance: a debate
van Duin, D., Barlow, G. D., & Nathwani, D. (2020) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlaa053 · Cited by 43
Sinto, R., Lie, K. C., Setiati, S., Suwarto, S., Nelwan, E. J., Djumaryo, D. H., Karyanti, M. R., Prayitno, A., Sumariyono, S., Moore, C. E., et al. (2022) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-022-01114-x · Cited by 40
Hossain, M. J., Jabin, N., Ahmmed, F., Sultana, A., Rahman, S. M. A., & Islam, M. R. (2023) · Health Science Reports · doi:10.1002/hsr2.1465 · Cited by 36
Challenges of Antimicrobial Resistance and Stewardship in Solid Organ Transplant Patients
So, M., & Walti, L. N. (2022) · Current Infectious Disease Reports · doi:10.1007/s11908-022-00778-1 · Cited by 32
Seneghini, M., Rüfenacht, S., Flury, B. B., Flury, D., Schlegel, M., Kuster, S. P., & Kohler, P. P. (2022) · Antimicrobial Stewardship & Healthcare Epidemiology · doi:10.1017/ash.2022.10 · Cited by 31
Novel Cecropin-4 Derived Peptides against Methicillin-Resistant Staphylococcus aureus
Peng, J., Mishra, B., Khader, R., LewisOscar, F., & Mylonakis, E. E. (2021) · Antibiotics · doi:10.3390/antibiotics10010036 · Cited by 30
Ryu, S., Hwang, Y., Ali, S. T., Kim, D., Klein, E. Y., Lau, E. H. Y., & Cowling, B. J. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab208 · Cited by 30
Dubey, P., Thakur, B., Reddy, S., Martinez, C. A., Nurunnabi, M., Manuel, S. L., Chheda, S., Bracamontes, C., & Dwivedi, A. K. (2021) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-021-03685-w · Cited by 28
Cameron, A., Esiovwa, R., Connolly, J., Hursthouse, A. S., & Henriquez, F. L. (2022) · Global Policy · doi:10.1111/1758-5899.13049 · Cited by 29
Ding, Y., Wang, J., Chen, Y., Yang, Y., & Liu, X. (2025) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2025.137740 · Cited by 28
D’Accolti, M., Soffritti, I., Bini, F., Mazziga, E., Arnoldo, L., Volta, A., Bisi, M., Antonioli, P., Laurenti, P., Ricciardi, W., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076535 · Cited by 28
Antimicrobial Resistance in Pseudomonas aeruginosa before and during the COVID-19 Pandemic
Serretiello, E., Manente, R., Dell’Annunziata, F., Folliero, V., Iervolino, D., Casolaro, V., Perrella, A., Santoro, E., Galdiero, M., Capunzo, M., et al. (2023) · Microorganisms · doi:10.3390/microorganisms11081918 · Cited by 26
Wardoyo, E. H., Suardana, I. W., Yasa, I. W. P. S., & Sukrama, I. D. M. (2021) · Iranian Journal of Microbiology · doi:10.18502/ijm.v13i2.5974 · Cited by 25
Colliers, A., Man, J. D., Adriaenssens, N., Verhoeven, V., Anthierens, S., Loof, H. D., Philips, H., Coenen, S., & Morreel, S. (2021) · Antibiotics · doi:10.3390/antibiotics10121488 · Cited by 22
Főldes, A., Székely, E., Voidăzan, S. T., & Dobreanu, M. (2022) · Antibiotics · doi:10.3390/antibiotics11030377 · Cited by 24
Patel, T. S., Sati, H. F., Lessa, F. C., Patel, P., Srinivasan, A., Hicks, L. A., Neuhauser, M. M., Tong, D., van der Heijden, M., Carvalho, S. C. A., et al. (2023) · The Lancet Microbe · doi:10.1016/s2666-5247(23)00256-2 · Cited by 22
Impact of the COVID-19 Pandemic on Antibiotic Resistant Infection Burden in U.S. Hospitals
Yek, C., Mancera, A. G., Diao, G., Walker, M. K., Neupane, M., Chishti, E. A., Amirahmadi, R., Richert, M. E., Rhee, C., Klompas, M., et al. (2025) · Annals of Internal Medicine · doi:10.7326/annals-24-03078 · Cited by 22
Learning From Mistakes: The Role of Phages in Pandemics
Alsaadi, A., Beamud, B., Easwaran, M., Abdelrahman, F. I., El‐Shibiny, A., Alghoribi, M. F., & Domingo‐Calap, P. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.653107 · Cited by 21
COVID‐19 and myasthenia gravis: A review of neurological implications of the SARS‐COV‐2
Shah, S. M. I., Yasmin, F., Memon, R. S., Jatoi, N. N., Savul, I. S., Kazmi, S., Monawwer, S. A., Zafar, M. D. B., Asghar, M. S., Tahir, M. J., et al. (2022) · Brain and Behavior · doi:10.1002/brb3.2789 · Cited by 21
Gattu, R., Ramesh, S. S., & Ramesh, S. (2024) · Microbial Pathogenesis · doi:10.1016/j.micpath.2024.106543 · Cited by 19
Najafzadeh, M. J., Shaban, T., Zarrinfar, H., Sedaghat, A., Hosseinikargar, N., Berenji, F., Jalali, M., Lackner, M., James, J. E., İlkit, M., et al. (2024) · Medical Mycology · doi:10.1093/mmy/myae031 · Cited by 19
Liu, H. H., Yaron, D., Piraino, A. S., & Kapelusznik, L. (2021) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-021-00472-5 · Cited by 20
Marcondes‐Braga, F. G., Murad, C. M., Belfort, D. D. S. P., Dantas, R. C. T., Lira, M. T. S. D. S., Aragão, C. A. D. S., Siciliano, R. F., Mangini, S., Seguro, L. F. B. C., de Campos, I. W., et al. (2021) · Transplantation · doi:10.1097/tp.0000000000003770 · Cited by 19
Barenghi, L., Barenghi, A., Garagiola, U. M., Blasio, A. D., Giannì, A. B., & Spadari, F. (2021) · Sensors · doi:10.3390/s22010049 · Cited by 17
Candida in COVID-19: Gut-Lung Axis, Dysbiosis, and Infections
Kordalewska, M., & Perlin, D. S. (2023) · Current Fungal Infection Reports · doi:10.1007/s12281-023-00476-y · Cited by 15
Duarte, N. B. A., & Takahashi, J. A. (2022) · Molecules · doi:10.3390/molecules27238210 · Cited by 15
Antibiotic prescribing patterns in patients hospitalized with COVID-19: lessons from the first wave
O’Kelly, B., Cronin, C., Connellan, D., Griffin, S., Connolly, S. P., McGrath, J., Cotter, A. G., McGinty, T., Muldoon, E. G., Sheehan, G., et al. (2021) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlab085 · Cited by 13
The menace of colistin resistance across globe: Obstacles and opportunities in curbing its spread
Seethalakshmi, P. S., Rajeev, R., Prabhakaran, A., Kiran, G. S., & Selvin, J. (2023) · Microbiological Research · doi:10.1016/j.micres.2023.127316 · Cited by 14
Probiotic-Based Sanitation in the Built Environment—An Alternative to Chemical Disinfectants
Ramos, A. M., & Frantz, A. L. (2023) · Applied Microbiology · doi:10.3390/applmicrobiol3020038 · Cited by 12
Kovacevic, A., Smith, D. R., Rahbé, E., Novelli, S., Henriot, P., Varon, E., Cohen, R., Lévy, C., Temime, L., & Opatowski, L. (2024) · eLife · doi:10.7554/elife.85701 · Cited by 12
Bini, F., Soffritti, I., D’Accolti, M., Mazziga, E., Caballero, J. D., David, S., Argimon, S., Aanensen, D. M., Volta, A., Bisi, M., et al. (2025) · BMC Genomics · doi:10.1186/s12864-025-11582-1 · Cited by 11
“The phenomenon of cross-resistance between disin-fectants and antimicrobials has been reported for several disinfectants and is associated with a further increase in AMR during the pandemic period [5, 10, 11].”
A scoping review of bacterial resistance among inpatients amidst the COVID-19 pandemic
Reffat, N., Schwei, R. J., Griffin, M., Pop-Vicas, A. E., Schulz, L. T., & Pulia, M. S. (2024) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2024.05.010 · Cited by 11
Antimicrobial susceptibility of bacteria isolated from urine cultures in Southern Turkey
Baran, C., & Küçükcan, A. (2022) · Current Urology · doi:10.1097/cu9.0000000000000144 · Cited by 9
Agnew, E., Davies, K., Viprey, V. F., Evans, S., Davis, G. L., Hope, R., Wilcox, M. H., Wingen-Heimann, S. M., & Robotham, J. V. (2023) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2023.02.004 · Cited by 9
COVID-19 impact on AMR: a rapid scoping review, equity analysis and evidence gap map study
Emdin, F., Orubu, E. S. F., Katwyk, S. R. V., Strong, K. M., Shaver, N., Abdullah, K., Asamoah, G. D., Skidmore, B., Chan, E., & Poirier, M. J. P. (2025) · BMJ Global Health · doi:10.1136/bmjgh-2024-018118 · Cited by 8
Rahimzadeh, G., Valadan, R., Rezai, S., Khosravi, M., Larijani, L. V., Sheidaei, S., Hevelaee, E. N., Movahedi, F. S., Rezai, R., & Rezai, M. S. (2024) · Iranian Journal of Microbiology · doi:10.18502/ijm.v16i3.15762 · Cited by 8
COVID-19: Questions of Antimicrobial Resistance
Dutta, S., & Haque, M. (2021) · Bangladesh Journal of Medical Science · doi:10.3329/bjms.v20i2.51527 · Cited by 8
Akinosoglou, K., Tsiakalos, A., Dimopoulou, I. D., Schinas, G., Polyzou, E., Kourea-Kremastinou, J., & Pitiriga, V. C. (2023) · The Journal of Antibiotics · doi:10.1038/s41429-023-00680-5 · Cited by 8
Soffritti, I., D’Accolti, M., Bini, F., Mazziga, E., Volta, A., Bisi, M., Mazzacane, S., & Caselli, E. (2025) · Microbial Biotechnology · doi:10.1111/1751-7915.70177 · Cited by 7
Alali, W. Q., Abdo, N. M., Alfouzan, W. A., & Dhar, R. (2022) · GERMS · doi:10.18683/germs.2022.1341 · Cited by 7
D’Accolti, M., Soffritti, I., Bini, F., Mazziga, E., & Caselli, E. (2024) · Microbial Biotechnology · doi:10.1111/1751-7915.14529 · Cited by 7
Törümküney, D., Kozlov, R. S., Sv, S., Kamble, P., Lezhnina, M., Galushkin, A., & Kundu, S. (2022) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkac218 · Cited by 7
Antimicrobial resistance and COVID-19 syndemic: Impact on public health
Vidyarthi, A. J., Das, A., & Chaudhry, R. (2021) · Drug Discoveries & Therapeutics · doi:10.5582/ddt.2021.01052 · Cited by 7
El-Ansary, M., & El-Ansary, A. R. (2023) · The Egyptian Journal of Medical Microbiology · doi:10.21608/ejmm.2023.277777 · Cited by 7
Antibiotic Resistance associated with the COVID-19 Pandemic: A Rapid Systematic ReviewPreprint
Langford, B. J., Soucy, J.-P. R., Leung, V., So, M., Kwan, A. T. H., Portnoff, J. S., Bertagnolio, S., Raybardhan, S., MacFadden, D. R., & Daneman, N. (2022) · medRxiv · doi:10.1101/2022.09.01.22279488 · Cited by 6
Rachina, S. A., Zakharenkova, P., Kozlov, R. S., Palagin, I. S., Mamchich, D. S., & Strelkova, D. A. (2023) · Advances in Public Health · doi:10.1155/2023/3306067 · Cited by 5
Clancy, C. J., & Nguyen, M. H. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa617 · Cited by 5
Self-citationZakharenkova, P., Rachina, S. A., Kozlov, R. S., Mamchich, D. S., Strelkova, D. A., & Shishkina, K. K. (2023) · Clinical Microbiology and Antimicrobial Chemotherapy · doi:10.36488/cmac.2023.3.247-259 · Cited by 4
Antimicrobial resistance during the COVID-19 pandemic: the missing patient perspective
Dahal, D., Sundar, S., Kullar, R., Kostova, N. M., & Dindial, K. (2021) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlab030 · Cited by 3
Indrasari, D. D., Koendhori, E. B., & Kuntaman, K. (2022) · International Journal of Health Sciences · doi:10.53730/ijhs.v6ns6.10535 · Cited by 3
What and where should the next antimicrobial resistance policies focus on?
Chan, O. S. K., Tun, H. M., Uchea, C., Wu, P., & Fukuda, K. (2022) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2022.08.003 · Cited by 4
Lubad, M. A., Abu-Helalah, M. A., Al-Hajaya, T. S., Al-Hutaibat, K. A., Aqel, A. A., & Alzoubi, H. M. (2023) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.17615 · Cited by 3
Lim, S. Y. C., Zhou, Y. P., Yii, D. Y. C., Chin, D. Z., Hung, K. C., Lee, L. W., Lim, J. L., Loo, L. W., Koomanan, N., Chua, N. G. S., et al. (2022) · Antibiotics · doi:10.3390/antibiotics11070846 · Cited by 3
Collignon, P., Beggs, J. J., & Robson, J. M. B. (2024) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlae125 · Cited by 2
Nabavi, A., Abolghasemi, S., Mardani, M., Tafti, M. F., Talebian, N., & Ghasemi, R. (2025) · Archives of Clinical Infectious Diseases · doi:10.5812/archcid-150568 · Cited by 2
Palagin, I. S., Rachina, S. A., Витальевна, С. М., Нижегородцева, И. А., Семеновна, П. У., Александровна, Г. С., Бурасова, Е. Г., Bagin, V. A., Domanskaya, O., Nathwani, D., et al. (2021) · Antibiotics · doi:10.3390/antibiotics10080892 · Cited by 2
Carroll, D. D., Cira, K., Archer, J., Shapiro, J. W., Pen, U.-Y., Tieri, D. A., Leonor, L., Roofchayee, N. D., Yee, S. S., Wahab, M., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.31.697156 · Cited by 2
Jameel, T. Y., Idris, A. B., Salman, M. A., & Ayvaz, A. (2026) · Scientific Reports · doi:10.1038/s41598-026-39078-2 · Cited by 1
Dhaliwal, J. S., Yusra, M. A. M. M., Muharram, S. H., Akkawi, M. E., Hussain, Z., Rahman, H. A., Kok, K. Y. Y., Dhaliwal, S. K. S., & Ming, L. C. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-049867 · Cited by 1
Two pandemics: the COVID-19 pandemic’s impact on future AMR collaboration in Europe
Lampi, E., Carelli, D. E., Pierre, J., & Rönnerstrand, B. (2023) · Humanities and Social Sciences Communications · doi:10.1057/s41599-023-01948-9 · Cited by 1
So, M., Morris, A. M., & Walker, A. M. (2021) · Journal of the Association of Medical Microbiology and Infectious Disease Canada · doi:10.3138/jammi-2021-0020 · Cited by 1
Al-Azawi, I. H., & Dhairh, S. H. (2022) · International Journal of Health Sciences · doi:10.53730/ijhs.v6ns6.10273 · Cited by 1
Antibiotic Use in Primary Care in Northern IrelandPreprint
Coleman, H. M., & Hadnett, N. (2023) · Preprints.org · doi:10.20944/preprints202312.0240.v1 · Cited by 1
Raksha, K., & Gopinath, P. (2021) · Journal of The Academy of Clinical Microbiologists · doi:10.4103/jacm.jacm_44_21
Advances and Challenges in Bacterial Phosphoproteomics
Prust, N. (2022) · Utrecht University Repository (Utrecht University) · doi:10.33540/878
Hoque, M. N., Akter, S., Mishu, I. D., Islam, M., Rahman, M. M., Akther, M., Islam, I., Hasan, M. M., Rahaman, M. M., Sultana, M., et al. (2022) · doi:10.22541/au.164864574.45709246/v1
Afshar, Z. M., Sayad, B., Janbakhsh, A., Ebrahimpour, S., & Babazadeh, A. (2023) · Minerva Respiratory Medicine · doi:10.23736/s2784-8477.21.01940-4
Naskar, S., Chakraborty, D., Majumdar, A. S., Debnath, F., & Dutta, S. (2023) · Indian Journal of Public Health · doi:10.4103/ijph.ijph_109_23
Lorenc, A., Badura, A., Karolak, M., Pałkowski, Ł., Kubik, Ł., & Buciński, A. (2024) · Pharmaceutical Research · doi:10.1007/s11095-024-03699-x
Evaluation of Clinical Distribution and Antimicrobial Resistance of Klebsiella Pneumoniae
Xie, L., Wu, Z., Wei, N., Zhang, L., Tang, J., & Wang, H. (2024) · Current Pharmaceutical Analysis · doi:10.2174/0115734129306621240813074201
Ding, Y., Wang, J., Chen, Y., Yang, Y., & Liu, X. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5082372
Cai, Q., Liu, S. J., Zhi, X.-Q., Tang, W., Wang, Y.-X., Lan, X., Wen, L., Luo, S., Wang, L., Sheng, J., et al. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1546013
Zhang, J., Jiao, F., Ge, Y., Cheng, B., & Guo, J. (2025) · Current Microbiology · doi:10.1007/s00284-025-04458-w
Sinto, R., Lie, K. C., Setiati, S., Suwarto, S., Nelwan, E. J., Djumaryo, D. H., Karyanti, M. R., Prayitno, A., Sumariyono, S., Moore, C. E., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19801940
Sinto, R., Lie, K. C., Setiati, S., Suwarto, S., Nelwan, E. J., Djumaryo, D. H., Karyanti, M. R., Prayitno, A., Sumariyono, S., Moore, C. E., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19801943
Antibiotic Use in Patients with COVID-19: Present and Future Perspectives
Bozo, S., Morghen, C. D. G., & Radaelli, A. (2022) · Albanian Journal of Natural and Technical Sciences · doi:10.67537/ajnts2701011
Metadata
- Authors
- Clancy, C. J., Buehrle, D. J., & Nguyen, M. H.
- Affiliations
- University of Pittsburgh (US)
- VA Pittsburgh Healthcare System (US)
- Corresponding author
- Clancy, Cornelius J
- Venue
- JAC-Antimicrobial Resistance
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-07-17
- Volume
- 2
- Issue
- 3
- Pages
- dlaa049-dlaa049
- ISSN
- 2632-1823 (ISSN-L)
- PMC
- PMC7454644
- OpenAlex
- W3044722900
- Cited by
- 102
- References
- 17
- Citations by year
- 2026: 3 · 2025: 9 · 2024: 9 · 2023: 18 · 2022: 27 · 2021: 31 · 2020: 5
- FWCI
- 12.05
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- JAC-Antimicrobial Resistance (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Physical Sciences › Environmental Science › Pollution › Pharmaceutical and Antibiotic Environmental Impacts
- Keywords
- COVID-19 pandemic, antimicrobial resistance, broad-spectrum antibiotic use, secondary infection, selection pressure, nosocomial infections, antibiotic prescribing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
